Navigation Links
WellPoint Reports Third Quarter 2007 Results
Date:10/24/2007

-- Strong performance in Commercial and Consumer Business drives

year-over-year earnings growth -- Selling, general and administrative expense ratio continues to improve,

declining by 90 basis points from the prior year quarter -- Company repurchased 30.1 million shares of its common stock during the

third quarter for $2.4 billion

INDIANAPOLIS, Oct. 24 /PRNewswire-FirstCall/ -- WellPoint, Inc. (NYSE: WLP) today announced that third quarter 2007 net income was $868.0 million, or $1.45 per share, which included $0.01 per share in net realized investment gains. Net income in the third quarter of 2006 was $810.8 million, or $1.29 per share, which included $0.04 per share in tax benefits due to a change in the Company's state tax apportionment factors, and net realized investment gains of $0.01 per share.

"We are pleased with our financial results for the third quarter and they reinforce the confidence we have in our future outlook. Our commercial health business performed particularly well during the quarter, and with more than 700,000 new members having joined WellPoint so far this year, we are now delivering more products and services to the marketplace than ever before," said Angela F. Braly, president and chief executive officer of WellPoint, Inc. "Importantly, we are continuing to find ways to operate more efficiently and reduce administrative costs as a percentage of revenue while providing superior service to our members."

"In 2008, we expect continued strong enrollment gains in National Accounts to be accompanied by new membership from our Medicaid contract awards in South Carolina and Indiana, and additional growth in our other commercial and senior businesses. Customers recognize the excellent value proposition we bring to the marketplace, and we expect to add more than 1,000,000 members in 2008. While we will release our detailed 2008 financial guidance in December, we6 (0.1%) (0.7%)

Total 34,805 34,190 34,101 1.8% 2.1%

Reportable Segment

Commercial & Consumer Business 30,031 29,612 29,669 1.4% 1.2%

Senior & State Sponsored 3,391 3,222 3,075 5.2% 10.3%

Other 1,383 1,356 1,357 2.0% 1.9%

Total 34,805 34,190 34,101 1.8% 2.1%

Specialty Metrics

PBM Prescription Volume (3) 93,694 90,308 95,685 3.7% (2.1%)

Behavioral Health Membership 20,168 16,048 16,937 25.7% 19.1%

Life and Disability Membership 5,665 5,956 5,970 (4.9%) (5.1%)

Dental Membership 5,008 5,193 5,270 (3.6%) (5.0%)

Vision Membership 2,367 1,255 1,536 88.6% 54.1%

Medicare Part D Membership (4) 1,596 1,569 1,568 1.7% 1.8%

(1) Effective January 1, 2007, WellPoint revised its definition of a

National Account to include multi-state employers primarily

headquartered in a WellPoint service area with 1,000 or more eligible

employees, of which at least 5% or more are located in a service area

outside of the headquarter state.

(2) During the fourth quarter of 2006, the Company's ownership of a joint

venture in Puerto Rico changed from a 50 percent ownership of a

Medicaid managed care subsidiary to a smaller percentage ownership in

the joint venture's parent company. Accordingly, for December 31, 2006

and subsequent periods, the Company no longer includes the 222,000

members related to this investment in its reported enrollment.

(3) Represents quarterly prescription volume at the Company's PBM

operation.

(4) Includes auto-assigned, stand-alone, Medicare Advantage, group waiver

and external PBM members with the prescription drug plan benefit.

WellPoint, Inc.

Consolidated Statements of Income

(Unaudited)

Three Months Ended

(In millions, except per share data) September 30

2007 2006 Change

Revenues

Premiums $13,905.6 $13,180.3 5.5%

Administrative fees 911.9 891.3 2.3%

Other revenue 149.2 150.4 (0.8%)

Total operating revenue 14,966.7 14,222.0 5.2%

Net investment income 257.7 222.8 15.7%

Net realized gains on investments 9.5 4.6 106.5%

Total revenues 15,233.9 14,449.4 5.4%

Expenses

Benefit expense 11,379.8 10,712.9 6.2%

Selling, general and administrative

expense

Selling expense 430.8 415.7 3.6%

General and administrative

expense 1,759.1 1,783.0 (1.3%)

Total selling, general and

administrative expense 2,189.9 2,198.7 (0.4%)

Cost of drugs 99.4 102.8 (3.3%)

Interest expense 119.6 105.6 13.3%

Amortization of other intangible

assets 73.8 74.8 (1.3%)

Total expenses 13,862.5 13,194.8 5.1%

Income before income taxes 1,371.4 1,254.6 9.3%

Income taxes 503.4 443.8 13.4%

Net income $868.0 $810.8 7.1%

Net income per diluted share $1.45 $1.29 12.4%

Diluted shares 597.0 630.6 (5.3%)

Benefit expense as a percentage of

premiums 81.8% 81.3% 50 bp

Selling, general and administrative

expense as a percentage of total

operating revenue 14.6% 15.5% (90) bp

Income before income taxes as a

percentage of total revenues 9.0% 8.7% 30 bp

WellPoint, Inc.

Consolidated Statements of Income

(Unaudited)

Nine Months Ended

(In millions, except per share data) September 30

2007 2006 Change

Revenues

Premiums $41,598.9 $38,678.0 7.6%

Administrative fees 2,760.3 2,690.4 2.6%

Other revenue 445.4 448.6 (0.7%)

Total operating revenue 44,804.6 41,817.0 7.1%

Net investment income 757.7 653.4 16.0%

Net realized gains (losses) on

investments 10.6 (11.4) -

Total revenues 45,572.9 42,459.0 7.3%

Expenses

Benefit expense 34,214.4 31,424.7 8.9%

Selling, general and administrative

expense

Selling expense 1,283.4 1,230.3 4.3%

General and administrative

expense 5,298.4 5,333.1 (0.7%)

Total selling, general and

administrative expense 6,581.8 6,563.4 0.3%

Cost of drugs 303.5 313.7 (3.3%)

Interest expense 322.6 303.5 6.3%

Amortization of other intangible

assets 215.5 223.1 (3.4%)

Total expenses 41,637.8 38,828.4 7.2%

Income before income taxes 3,935.1 3,630.6 8.4%

Income taxes 1,448.8 1,336.8 8.4%

Net income $2,486.3 $2,293.8 8.4%

Net income per diluted share $4.06 $3.54 14.7%

Diluted shares 612.6 647.1 (5.3%)

Benefit expense as a percentage of

premiums 82.2% 81.2% 100 bp

Selling, general and administrative

expense as a percentage of total

operating revenue 14.7% 15.7% (100) bp

Income before income taxes as a

percentage of total revenues 8.6% 8.6% 0 bp

WellPoint, Inc.

Consolidated Balance Sheets

September 30, December 31,

(In millions) 2007 2006

(Unaudited)

Assets

Current assets:

Cash and cash equivalents $2,824.0 $2,602.1

Investments available-for-sale, at

fair value 3,927.2 2,449.9

Other invested assets, current 38.8 72.8

Accrued investment income 161.6 157.2

Premium and self-funded

receivables 2,801.0 2,335.3

Other receivables 1,161.8 1,172.7

Securities lending collateral 891.5 904.7

Deferred tax assets, net 563.5 642.6

Other current assets 1,318.3 1,284.5

Total current assets 13,687.7 11,621.8

Long-term investments available-for-sale,

at fair value 14,884.2 15,687.4

Property and equipment, net 957.8 988.6

Goodwill 13,544.5 13,383.5

Other intangible assets 9,296.9 9,396.2

Other noncurrent assets 528.6 497.4

Total assets $52,899.7 $51,574.9

Liabilities and shareholders' equity

Liabilities

Current liabilities:

Policy liabilities:

Medical claims payable $5,785.4 $5,290.3

Reserves for future policy

benefits 74.1 76.3

Other policyholder liabilities 2,212.4 2,055.7

Total policy liabilities 8,071.9 7,422.3

Unearned income 985.7 987.9

Accounts payable and accrued

expenses 3,046.1 3,242.2

Income taxes payable 22.0 538.2

Security trades pending payable 92.0 124.8

Securities lending payable 891.5 904.7

Current portion of long-term debt 321.5 521.0

Other current liabilities 1,648.3 1,397.4

Total current liabilities 15,079.0 15,138.5

Long-term debt, less current portion 8,381.0 6,493.2

Reserves for future policy benefits,

noncurrent 654.2 646.9

Deferred tax liability, net 2,914.4 3,350.2

Other noncurrent liabilities 2,197.2 1,370.3

Total liabilities 29,225.8 26,999.1

Shareholders' equity

Common stock 5.7 6.1

Additional paid-in capital 18,976.9 19,863.5

Retained earnings 4,612.0 4,656.1

Accumulated other comprehensive

income 79.3 50.1

Total shareholders' equity 23,673.9 24,575.8

Total liabilities and shareholders'

equity $52,899.7 $51,574.9

WellPoint, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

Nine Months Ended September 30

(In millions) 2007 2006

Operating activities

Net income $2,486.3 $2,293.8

Adjustments to reconcile net income

to net cash provided by operating

activities:

Net realized (gains) losses

on investments (10.6) 11.4

Loss on disposal of assets 10.3 0.4

Deferred income taxes (229.4) 27.8

Amortization, net of

accretion 350.7 348.9

Depreciation expense 91.4 101.3

Share-based compensation 153.6 212.3

Excess tax benefits from

share-based compensation (141.4) (113.4)

Changes in operating assets

and liabilities, net of

effect of business

combinations:

Receivables, net (441.4) (676.2)

Other invested

assets, current 34.4 (98.5)

Other assets (61.0) (229.4)

Policy liabilities 638.0 806.8

Unearned income (3.4) 0.6

Accounts payable and

accrued expenses (199.0) (45.2)

Other liabilities 158.3 122.7

Income taxes 424.8 (150.0)

Other, net (21.3) -

Net cash provided by operating

activities 3,240.3 2,613.3

Investing activities

Purchases of fixed maturity

securities (7,131.4) (9,310.2)

Proceeds from sales and maturities of

fixed maturity securities 5,914.7 9,121.1

Purchase of equity securities (1,147.7) (2,136.1)

Proceeds from sales of equity

securities 1,750.9 1,841.5

Changes in securities lending

collateral 13.2 490.9

Purchases of subsidiaries, net of

cash acquired (298.5) (25.0)

Purchases of property and equipment (211.5) (130.5)

Proceeds from sales of property and

equipment 52.6 11.3

Other, net (30.9) (24.7)

Net cash used in investing activities (1,088.6) (161.7)

Financing activities

Net (repayments of) proceeds from

commercial paper borrowings (97.3) 29.0

Proceeds from long-term borrowings 1,978.3 2,668.9

Repayment of long-term borrowings (206.2) (2,159.5)

Changes in securities lending payable (13.2) (490.9)

Changes in bank overdrafts (12.9) 414.5

Repurchase and retirement of common

stock (4,325.3) (4,000.0)

Proceeds from exercise of employee

stock options and employee stock

purchase plan 605.4 462.3

Excess tax benefits from share-based

compensation 141.4 113.4

Net cash used in financing activities (1,929.8) (2,962.3)

Change in cash and cash equivalents 221.9 (510.7)

Cash and cash equivalents at

beginning of period 2,602.1 2,740.2

Cash and cash equivalents at end of

period $2,824.0 $2,229.5

WellPoint, Inc.

Reconciliation of Medical Claims Payable

Nine Months Ended

September 30 Year Ended December 31

(In millions) 2007 2006 2006 2005 2004

(Unaudited)

Gross medical claims

payable, beginning of

period $5,290.3 $4,853.4 $4,853.4 $4,134.0 $1,836.0

Ceded medical claims

payable, beginning of

period (51.0) (27.7) (27.7) (31.9) (8.7)

Net medical claims

payable, beginning of

period 5,239.3 4,825.7 4,825.7 4,102.1 1,827.3

Business combinations

and purchase

adjustments 15.2 (6.4) (6.4) 784.5 2,331.0

Net incurred medical

claims:

Current year 34,558.1 31,845.2 42,613.2 32,865.6 15,344.9

Prior years

(redundancies)(1) (336.2) (576.5) (617.7) (644.9) (171.9)

Total net incurred

medical claims 34,221.9 31,268.7 41,995.5 32,220.7 15,173.0

Net payments

attributable to:

Current year medical

claims 29,053.6 26,830.6 37,486.0 28,997.1 12,453.2

Prior years medical

claims 4,693.4 3,989.3 4,089.5 3,284.5 2,776.0

Total net payments 33,747.0 30,819.9 41,575.5 32,281.6 15,229.2

Net medical claims

payable, end of period 5,729.4 5,268.1 5,239.3 4,825.7 4,102.1

Ceded medical claims,

end of period 56.0 41.0 51.0 27.7 31.9

Gross medical claims

payable, end of period $5,785.4 $5,309.1 $5,290.3 $4,853.4 $4,134.0

Current year medical

claims paid as a

percent of current

year net incurred

medical claims 84.1% 84.3% 88.0% 88.2% 81.2%(2)

Prior year redundancies

in the current period

as a percent of prior year

net medical claims

payables less prior year

redundancies in the

current period 6.9% 13.6% 14.7% 18.7% 10.4%

Prior year redundancies

in the current period

as a percent of prior

year net incurred

medical claims -

as reported (3) 0.8% 1.8% 1.9% 4.2% 1.4%

Prior year redundancies

in the current period

as a percent of prior

year net incurred

medical claims -

adjusted for

acquisitions (3) 0.8% 1.5% 1.6% 2.1% 1.4%

(1) Negative amounts reported for net incurred medical claims related to

prior years result from claims being settled for amounts less than

originally estimated.

(2) This ratio is impacted by having only one month of net incurred

medical claims and payments for the former WellPoint Health Networks

Inc. ("WHN") in 2004. If WHN had not been included in 2004, current

year medical claims payments would have been $12,057.7 million,

current year net incurred medical claims would have been $13,835.1

million and the adjusted ratio would have been 87.2%.

(3) For all periods presented, except for the year ended December 31, 2004

and the nine months ended September 30, 2007, the reported ratio of

prior year redundancies in the current period to prior year net

incurred medical claims is impacted by certain acquisitions (the

former WellChoice, Inc. in 2005 and WHN in 2004). The Company has

provided ratios adjusted for these acquisitions in order to

demonstrate these impacts. Refer to the table entitled,

"Reconciliation of Medical Claims Payable - Adjusted Ratios" for

details regarding the respective calculation methodologies.

WellPoint, Inc.

Reconciliation of Medical Claims Payable - Adjusted Ratios

(Unaudited)

Note: Below are reconciliations for the ad remain committed to our earnings per share growth target of at least 15 percent," added Braly.

"We are committed to managing capital in a manner that improves our business and enhances equity returns for our shareholders," said Wayne S. DeVeydt, chief financial officer of WellPoint, Inc. "We continued to execute on our share repurchase program during the third quarter, and through the first nine months of this year, we have repurchased 54.4 million shares of our common stock for $4.3 billion."

CONSOLIDATED HIGHLIGHTS

Membership: Medical enrollment totaled 34.8 million members at September 30, 2007, an increase of 615,000 members from 34.2 million reported at September 30, 2006. The increase was driven by National Accounts and State Sponsored business, which added 511,000 members and 336,000 members, respectively, over the last twelve months. Growth from the prior year in State Sponsored business excludes the impact of the change in the Company's 50 percent ownership interest in a joint venture in Puerto Rico to a smaller percentage ownership in the joint venture's parent company. Accordingly, the Company no longer includes the 222,000 members related to this investment in its enrollment but continues to realize financial benefits from these members.

Enrollment increased by 38,000 members during the third quarter of 2007, as growth of 100,000 members in the Company's Blue-branded businesses was partially offset by declines of 62,000 members in the non-Blue branded businesses.

Operating Revenue: Operating revenue was $15.0 billion in the third quarter of 2007, an increase of 5.2 percent from $14.2 billion in the prior year third quarter. The increase resulted primarily from disciplined pricing in the Company's Local Group business and growth in State Sponsored and Medicare Advantage membership.

Benefit Expense Ratio: The benefit expense ratio was 81.8 percent in the third quarter of 2007, an increase of 50 basis points from 81.3 pejusted ratios of prior year redundancies in the current period to prior year net incurred medical claims that are included in table entitled, "Reconciliation of Medical Claims Payable."

Ratio for the Nine Months Ended September 30, 2006

This ratio is impacted by having no net incurred medical

claims for the former WellChoice, Inc. ("WC") in 2005.

Net incurred medical claims related to prior years

(redundancies) - nine months ended September 30, 2006

(As Reported) $576.5

Net incurred medical claims - year ended

December 31, 2005 (As Reported) $32,865.6

Ratio (As Reported) 1.8%

Net incurred medical claims - year ended

December 31, 2005 (Comparable Basis) (1) $37,676.0

Ratio (As Adjusted) 1.5%

(1) Represents comparable benefit expense, assuming

WC had been owned for the entire year ended

December 31, 2005.

Ratio for the Year Ended December 31, 2006

This ratio is impacted by having no net incurred medical

claims for the former WellChoice, Inc. ("WC") in 2005.

Net incurred medical claims related to prior years

(redundancies) - year ended December 31, 2006

(As Reported) $617.7

Net incurred medical claims - year ended

December 31, 2005 (As Reported) $32,865.6

Ratio (As Reported) 1.9%

Net incurred medical claims - year ended

December 31, 2005 (Comparable Basis) (1) $37,676.0

Ratio (As Adjusted) 1.6%

(1) Represents comparable benefit expense,

assuming WC had been owned for the entire

year ended December 31, 2005.

Ratio for the Year Ended December 31, 2005

This ratio is impacted by having only one month

of net incurred medical claims for the former

WellPoint Health Networks Inc. ("WHN") in 2004.

Net incurred medical claims related to prior

years (redundancies) - year ended

December 31, 2005 (As Reported) $644.9

Net incurred medical claims - year ended

December 31, 2004 (As Reported) $15,344.9

Ratio (As Reported) 4.2%

Net incurred medical claims - year ended

December 31, 2004 (Comparable Basis) (2) $30,819.1

Ratio (As Adjusted) 2.1%

(2) Represents comparable benefit expense,

assuming WHN had been owned for the entire year

ended December 31, 2004.

WellPoint, Inc.

Operating Cash Flow as a Multiple of Net Income

(Unaudited)

($ In Millions) Three Months Ended September 30, 2007(1)

Average Monthly

As Reported CMS Payment Adjusted

Operating cash flow $533.3 $538.9 $1,072.2

Net income $868.0 - $868.0

Operating cash flow as a

multiple of net income 0.6 - 1.2

(1) Operating cash flow for the three months ended September 30, 2007,

included the receipt of only two monthly CMS payments, which averaged

approximately $538.9 million per month. Due to the magnitude of these

payments, the Company has presented the "Operating Cash Flow as a

Multiple of Net Income" metric on an adjusted basis (which adds an

average monthly CMS payment to third quarter 2007 operating cash flow)

in order to facilitate period-to-period analysis. SAFE HARBOR STATEMENT UNDER THE PRIVATE SECURITIES LITIGATION REFORM ACT OF

1995

This document contains certain forward-looking information about WellPoint, Inc. ("WellPoint") that is intended to be covered by the safe harbor for "forward-looking statements" provided by the Private Securities Litigation Reform Act of 1995. Forward-looking statements are statements that are not generally historical facts. Words such as "expect(s)", "feel(s)", "believe(s)", "will", "may", "anticipate(s)", "intend", "estimate", "project" and similar expressions are intended to identify forward-looking statements. These statements include, but are not limited to, financial projections and estimates and their underlying assumptions; statements regarding plans, objectives and expectations with respect to future operations, products and services; and statements regarding future performance. Such statements are subject to certain risks and uncertainties, many of which are difficult to predict and generally beyond the control of WellPoint, that could cause actual results to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include: those discussed and identified in public filings with the U.S. Securities and Exchange Commission ("SEC") made by WellPoint; increased government regulation of health benefits, managed care and pharmacy benefit management operations; trends in health care costs and utilization rates; our ability to secure sufficient premium rate increases; our ability to contract with providers consistent with past practice; competitor pricing below market trends of increasing costs; reduced enrollment, as well as a negative change in our health care product mix; risks and uncertainties regarding the Medicare Part D Prescription Drug benefits program, including potential uncollectability of receivables resulting from processing and/or verifying enrollment (including facilitated enrollment), inadequacy of underwriting assumptions, inability to receive and process information, uncollectability of premium from members, increased pharmaceutical costs, and the underlying seasonality of the business; a downgrade in our financial strength ratings; litigation and investigations targeted at health benefits companies and our ability to resolve litigation and investigations within estimates; our ability to achieve expected synergies and operating efficiencies in the WellChoice, Inc. acquisition within the expected time frames or at all, and to successfully integrate our operations; our ability to meet expectations regarding repurchases of shares of our common stock; funding risks with respect to revenue received from participation in Medicare and Medicaid programs and the complex regulations imposed on Medicare fiscal intermediaries; events that result in negative publicity for the health benefits industry; failure to effectively maintain and modernize our information systems and e-business organization and to maintain good relationships with third party vendors for information system resources; events that may negatively affect our license with the Blue Cross and Blue Shield Association; possible impairment of the value of our intangible assets if future results do not adequately support goodwill and other intangible assets; intense competition to attract and retain employees; unauthorized disclosure of member sensitive or confidential information; changes in the economic and market conditions, as well as regulations, applicable to our investment portfolios; possible restrictions in the payment of dividends by our subsidiaries and increases in required minimum levels of capital and the potential negative affect from our substantial amount of outstanding indebtedness; general risks associated with mergers and acquisitions; various laws and our governing documents may prevent or discourage takeovers and business combinations; potential hedging activities in our common stock; future bio-terrorist activity or other potential public health epidemics; and general economic downturns. Readers are cautioned not to place undue reliance on these forward-looking statements that speak only as of the date hereof. Except to the extent otherwise required by federal securities law, WellPoint does not undertake any obligation to republish revised forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Readers are also urged to carefully review and consider the various disclosures in WellPoint's SEC reports.

rcent in the prior year quarter. The increase was driven by an increase in the Specialty, Senior, and State Sponsored Business reporting segment, partially offset by a decline in the benefit expense ratio for the Commercial and Consumer Business segment.

The third quarter 2007 benefit expense ratio in the Company's Senior business was higher than anticipated primarily due to the Centers for Medicare & Medicaid Services ("CMS") reconciliation of 2006 Medicare Part D claims activity. This process resulted in an amount due to CMS for Medicare Part D risk sharing that was higher than the Company's original projections. Accordingly, the Company recorded a charge in the third quarter that increased the consolidated benefit expense ratio by approximately 40 basis points. This charge related to claims activity for 2006 and 2007.

Higher claims experience in State Sponsored operations also increased the Company's overall benefit expense ratio from the third quarter of 2006. Contract negotiations in Connecticut and California are on-going and the Company continues to anticipate favorable resolutions that will allow it to continue to administer programs in both states into the future with acceptable margins. The Company expects to receive rate increases retroactive to July 1, 2007, in Connecticut, and October 1, 2007, in California.

These increases were partially offset by a decline in the Commercial and Consumer Business benefit expense ratio from the third quarter of 2006, reflecting the Company's commitment to disciplined pricing. The results from this segment represent over 70 percent of consolidated operating revenue.

Premium and Cost Trends: Trends include Local Group and Individual fully- insured businesses.

For the rolling 12-month period ended September 30, 2007, the primary driver of medical trend was the increase in unit cost. The Company continues to price its business so that expected premium yield exceeds total cost trend, where total cost trend includes medical costs and selling, general and administrative ("SG&A") expense.

Based on medical trends through the first three quarters of 2007, the Company continues to believe its 2007 medical cost trend estimate of less than 8.0 percent is appropriate.

SG&A Expense Ratio: The SG&A expense ratio was 14.6 percent in the third quarter of 2007, a decrease of 90 basis points from 15.5 percent in the third quarter of 2006. The ratio improved year-over-year due to the Company's continued focus on optimizing administrative costs and spreading expenses across a growing revenue base. General and administrative expenses were $23.9 million lower in the third quarter of 2007 than in the prior year period, despite the addition of more than 700,000 new members to the Company's enrollment base during 2007.

Operating Cash Flow: For the nine months ended September 30, 2007, operating cash flow totaled $3.2 billion, or 1.3 times net income. Third quarter 2007 operating cash flow totaled $533.3 million, as the Company received only two CMS monthly payments averaging $538.9 million each. For the quarter, operating cash flow was 0.6 times net income. If three monthly CMS payments had been received during the quarter, operating cash flow would have been 1.2 times net income.

Days in Claims Payable: Days in claims payable as of September 30, 2007, was 46.8 days, an increase of 1.3 days from 45.5 days as of June 30, 2007. The increase was primarily due to lower benefit expense per day, increased accruals for provider settlements, and the timing of pharmacy benefit management ("PBM") payments, partially offset by a reduction in the length of time between the date of service and claims payment.

Share Repurchase Program: During the third quarter of 2007, the Company repurchased 30.1 million shares of its common stock for $2.4 billion. At September 30, 2007, cash and investments held at the parent company and available for general corporate use totaled $2.0 billion.

REPORTABLE SEGMENTS

WellPoint, Inc. has the following reportable segments: Commercial and Consumer Business ("CCB"), Specialty, Senior, and State Sponsored Business ("4SB"), and Other, which includes FEP business, National Government Services, Inc., intersegment sales and expense eliminations, and corporate expenses not allocated to the other reportable segments.

Operating revenue and operating gain are the key measures used by management to evaluate performance in each segment.

WellPoint, Inc.

Reportable Segment Highlights

(Unaudited)

(In millions) Three Months Ended September 30

2007 2006 Change

Operating Revenue

CCB $10,561.0 $10,215.1 3.4%

4SB 3,373.6 2,912.7 15.8%

Other:

External Customers 1,446.4 1,467.1 (1.4%)

Intersegment Eliminations (414.3) (372.9) (11.1%)

Other 1,032.1 1,094.2 (5.7%)

Total Operating Revenue 14,966.7 14,222.0 5.2%

Operating Gain (Loss)

CCB $1,100.0 $936.4 17.5%

4SB 224.0 284.3 (21.2%)

Other (26.4) (13.1) (101.5%)

Operating Margin

CCB 10.4% 9.2% 120 bp

4SB 6.6% 9.8% (320) bp

`

WellPoint, Inc.

Reportable Segment Highlights

(Unaudited)

(In millions) Nine Months Ended September 30

2007 2006 Change

Operating Revenue

CCB $31,494.8 $30,280.9 4.0%

4SB 10,113.8 8,537.7 18.5%

Other:

External Customers 4,421.2 4,053.9 9.1%

Intersegment Eliminations (1,225.2) (1,055.5) (16.1%)

Other 3,196.0 2,998.4 6.6%

Total Operating Revenue 44,804.6 41,817.0 7.1%

Operating Gain (Loss)

CCB $3,127.7 $2,824.8 10.7%

4SB 580.0 737.3 (21.3%)

Other (2.8) (46.9) 94.0%

Operating Margin

CCB 9.9% 9.3% 60 bp

4SB 5.7% 8.6% (290) bp

Commercial and Consumer Business: Operating gain for the CCB segment was $1.1 billion in the third quarter of 2007, an increase of 17.5 percent compared to $936.4 million in the third quarter of 2006. Operating performance continued to improve in this segment primarily due to disciplined pricing in the Local Group business. Employers and consumers continue to find excellent value in the Company's product offerings, which include broad and cost-effective provider networks, innovative and flexible health benefit designs, and distinctive customer service.

The CCB benefit expense ratio declined by 40 basis points from the third quarter of 2006, and the SG&A expense ratio continued to improve, as the Company remained disciplined in its pricing and continued to leverage administrative costs across a growing revenue base.

Specialty, Senior, and State Sponsored Business: Operating gain for the 4SB segment totaled $224.0 million in the third quarter of 2007, a decrease of 21.2 percent compared to $284.3 million in the third quarter of 2006. The decrease was primarily attributable to higher-than-expected costs recorded in the current quarter as a result of the accrual for CMS Medicare Part D 2006 and 2007 risk sharing payments.

Other: Operating loss for the Other segment totaled $26.4 million in the third quarter of 2007, which compares to an operating loss of $13.1 million in the third quarter of 2006. The change resulted primarily from higher corporate expenses during the quarter.

OUTLOOK

Full Year 2007:

-- The Company now expects net income of $5.56 per share, representing

growth of 15.4% over 2006.

-- Year-end medical enrollment is now expected to be approximately

34.9 million members, representing growth for the year of

800,000 members.

-- Operating revenue is now expected to total approximately $60.2 billion.

-- The benefit expense ratio is now expected to be approximately

82.0 percent.

-- The SG&A expense ratio is now expected to be approximately

14.7 percent.

-- The Company now expects operating cash flow of $4.2 billion, or

1.2 times net income.

Full Year 2008:

-- The Company is in the process of finalizing its 2008 annual plan and

remains committed to its earnings per share growth model of at least

15 percent. The Company will provide formal guidance for 2008 at its

Investor Conference on December 11, 2007. A live webcast of this event

will be available at http://www.wellpoint.com.

Basis of Presentation

1. Operating gain is defined as operating revenue less benefit expense,

selling expense, general and administrative expense, and cost of drugs.

Operating gain is used to analyze profit or loss on a segment basis.

Consolidated operating gain is a non-GAAP measure.

2. Operating margin is defined as operating gain divided by operating

revenue.

3. Certain prior period amounts have been reclassified to conform to

current period presentation.

Conference Call and Webcast

Management will host a conference call and webcast today at 8:30 a.m. Eastern Daylight Time ("EDT") to discuss its third quarter earnings results and updated outlook. The conference call should be accessed at least 15 minutes prior to the start of the call with the following numbers:

888-423-3268 (Domestic) 800-475-6701 (Domestic Replay)

651-291-5254 (International) 320-365-3844 (International Replay)

An access code is not required for today's conference call. The access code for the replay is 857271. The replay will be available from 1:45 p.m. EDT today until the end of the day on November 7, 2007. The call will also be available through a live webcast at http://www.wellpoint.com under "Investor Info." A webcast replay will be available following the call.

About WellPoint, Inc.

WellPoint's mission is to improve the lives of the people it serves and the health of its communities. WellPoint, Inc. is the largest health benefits company in terms of commercial membership in the United States. Through its nationwide networks, the company delivers a number of leading health benefit solutions through a broad portfolio of integrated health care plans and related services, along with a wide range of specialty products such as life and disability insurance benefits, pharmacy benefit management, dental, vision, behavioral health benefit services, as well as long term care insurance and flexible spending accounts. Headquartered in Indianapolis, Indiana, WellPoint is an independent licensee of the Blue Cross and Blue Shield Association and serves its members as the Blue Cross licensee for California; the Blue Cross and Blue Shield licensee for Colorado, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri (excluding 30 counties in the Kansas City area), Nevada, New Hampshire, New York (as Blue Cross Blue Shield in 10 New York City metropolitan and surrounding counties and as Blue Cross or Blue Cross Blue Shield in selected upstate counties only), Ohio, Virginia (excluding the Northern Virginia suburbs of Washington, D.C.), Wisconsin; and through UniCare. Additional information about WellPoint is available at http://www.wellpoint.com.

WellPoint, Inc.

Medical Membership & Specialty Metrics Summary

(Unaudited and in Thousands)

Change from

Sept.30, Sept.30, Dec.31, Sept.30, Dec.31,

Medical Membership 2007 2006 2006 2006 2006

Customer Type

Local Group (1) 16,649 16,665 16,766 (0.1%) (0.7%)

Individual 2,432 2,508 2,488 (3.0%) (2.3%)

National Accounts (1) 6,388 6,225 6,136 2.6% 4.1%

BlueCard 4,562 4,214 4,279 8.3% 6.6%

Total National 10,950 10,439 10,415 4.9% 5.1%

Senior 1,250 1,195 1,193 4.6% 4.8%

State Sponsored (2) 2,141 2,027 1,882 5.6% 13.8%

FEP 1,383 1,356 1,357 2.0% 1.9%

Total 34,805 34,190 34,101 1.8% 2.1%

Funding Arrangement

Self-Funded 17,571 16,937 16,745 3.7% 4.9%

Fully-Insured 17,234 17,253 17,35
'/>"/>

SOURCE WellPoint, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Autopsy reports could be valuable and informative
2. China reports declining number of SARS Cases
3. Russia Reports First SARS Case
4. Research reports that c-section deliveries are rising
5. Jharkhand reports 13,000 Malaria cases
6. Uganda Reports Failure To Contain Sleeping Sickness
7. WHO reports 36 million deaths world wide due to chronic diseases
8. Reports of Hantavirus infection in India raise concerns
9. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
10. China Reports Yet Another Bird Flu Case
11. China reports seventh bird flu victim
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2016)... ... 11, 2016 , ... "What holds you back from ... a question as a challenge for his readers to examine the full scale ... (published by Partridge Singapore), Clarke explores the subject with more depth, revealing time-honored ...
(Date:2/11/2016)... , ... February 11, 2016 , ... ... of a master charity program created to assist the people of their local ... closely with nonprofit organizations and community leaders. Their hope is to bring awareness ...
(Date:2/11/2016)... ... February 11, 2016 , ... Talix today announced ... , will be presenting at the 2016 HIMSS Annual Conference & Exhibition, taking ... During his session, “ Coding for Care: Using Data Analytics for Risk Adjustment ...
(Date:2/11/2016)... ... 11, 2016 , ... The annual list showcases the 20 Most Promising SharePoint ... dedication and commitment to the SharePoint ecosystem. A panel of experts and members ... is to recognize and promote technology entrepreneurship. , The survey was made at ...
(Date:2/11/2016)... D.C. (PRWEB) , ... February 11, 2016 , ... ... will be exhibiting at the American Academy of Dermatology Annual Meeting at the ... USA's goal is to raise awareness for both the condition of hyperhidrosis (excessive ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)... DIEGO , Feb. 11, 2016 ... groundbreaking cell-isolation method that opens the door to ... until now have been impossible to isolate with ... to isolate specific tumor types in various stages ... genetic variants of these cells that are clinically ...
(Date:2/11/2016)... , Feb. 11, 2016  AcelRx Pharmaceuticals, Inc. ... presentation will be made at the 38th annual ... Wound Care Symposium, which is being held February 14-18, ... conference covers the latest advancements in wound healing, burn ... American Burn Association, Australian-New Zealand Burns Association, Academy of ...
(Date:2/11/2016)... 11, 2016  Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) ... into a Controlled Equity Offering SM Sales Agreement ... Michael Macaluso , Chairman and CEO, stated "During our ... not currently raising money and that we have enough ... and still complete all of our current objectives and ...
Breaking Medicine Technology: